Moolec Science S.A. - MLEC Company Cumulative Debt

The current debt volume of Moolec Science SA (MLEC) demonstrates the business's financial leverage, where 0.03 captures the magnitude of this parameter. The company's revenues are based on the sale of molecular farming licenses for the synthesis of animal proteins in plants. Such an ecosystem creates sustainable nutrition through the integration of proteins into seeds. This innovative approach enables the rapid production of porcine protein within soy.

This indicator assesses the real level of corporate leverage in dynamics relative to competitors, eliminating information gaps between quarterly reports to reveal the true debt burden. By analyzing the debt trajectory on GURU.Markets, an investor can evaluate how effectively Moolec Science SA (MLEC) finances long-term field trials and overcomes the regulatory barriers of molecular farming through leveraged capital.